文献速递临床试验与 GCP流行病学与生物统计

社区中新生血管性年龄相关性黄斑变性早期检测的持续性、依从性与可接受性评估:DORADO随机对照试验研究方案

Early Detection Of neovascular age-Related mAcular Degeneration in the cOmmunity assessing persistence, adherence and acceptability: study protocol for the DORADO randomized controlled trial.
PubMed 文献 · Trials · 2025-12-30

DORADO随机对照试验将在英国社区眼科诊所招募130名参与者,随机分为标准护理组(12个月时随访一次)和干预组(每3个月评估一次),为期12个月,评估社区早期检测新生血管性年龄相关性黄斑变性(nAMD)项目的持续性、依从性和可接受性。

要点

  • DORADO试验评估社区nAMD早期检测项目的持续性、依从性与可接受性。
  • 130名参与者随机分为标准护理组和每3个月评估一次的干预组,研究为期12个月。
  • 所有参与者在基线和12个月时完成NEI-VFQ-25、MacDQoL、PHQ9和EQ-5D-3L问卷。

核心结论

  • DORADO研究旨在评估基于社区的nAMD早期检测项目的持续性、依从性和可接受性。

研究设计与样本

  • 随机对照试验,计划从英国社区眼科诊所招募130名参与者。
  • 参与者随机分为标准护理组(12个月时随访一次)或干预组(每3个月评估一次),研究终点为12个月。
  • 所有参与者在基线和12个月时完成NEI-VFQ-25、MacDQoL、PHQ9和EQ-5D-3L问卷;所有参与者和招募研究者还在12个月时完成可接受性理论框架问卷。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neovascular age-related macular degeneration (nAMD) is the leading cause of blindness in the Western world, with an estimated 40,000 newly diagnosed cases in the UK every year. Early detection and treatment of nAMD are important to achieve good visual acuity and quality-of-life (QoL) outcomes. Whilst early treatment of the second eye, following detection using optical coherence tomography (OCT) imaging, has shown maintenance of visual acuity and health-related QoL and reduced health and social care costs, there is a paucity of information about the benefits of early detection of nAMD in the first eye. In particular, although it is reasonable to consider a form of targeted screening of those most likely to develop nAMD, it is unclear if those invited would adhere to such a programme. METHODS: In this randomized controlled trial, 130 participants will be recruited from community-based eye healthcare practices within the UK whilst attending their routine appointment. Participants will be randomized to either a standard care arm to attend a further follow-up appointment at 12 months, or an intervention arm, attending every 3 months for assessment. The end of study is at 12 months. All participants will complete the NEI-VFQ-25, MacDQoL, PHQ9 and EQ-5D-3L questionnaires at baseline and 12 months. In addition, all participants and recruiting investigators will complete the Theoretical Framework of Acceptability questionnaire at 12 months. DISCUSSION: The DORADO study aims to assess the persistence and adherence to and acceptability of a community-based programme for the early detection of nAMD. TRIAL REGISTRATION: ISRCTN10005321. Registered on 08 November 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Hanson RLW, Airody A, Saad A, et al. Early Detection Of neovascular age-Related mAcular Degeneration in the cOmmunity assessing persistence, adherence and acceptability: study protocol for the DORADO randomized controlled trial. Trials. 2025. PMID: 41466299. doi:10.1186/s13063-025-09393-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。